|
CPT1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.638240E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.319200E-03 |
| Normal-vs-Stage2 |
2.327000E-01 |
| Normal-vs-Stage3 |
2.873400E-01 |
| Normal-vs-Stage4 |
1.719030E-01 |
| Stage1-vs-Stage2 |
9.149200E-01 |
| Stage1-vs-Stage3 |
1.059800E-03 |
| Stage1-vs-Stage4 |
3.716600E-03 |
| Stage2-vs-Stage3 |
9.848400E-02 |
| Stage2-vs-Stage4 |
6.516200E-02 |
| Stage3-vs-Stage4 |
6.623800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.457890E-03 |
| Normal-vs-AfricanAmerican |
6.761700E-02 |
| Normal-vs-Asian |
8.204800E-01 |
| Caucasian-vs-AfricanAmerican |
4.350400E-01 |
| Caucasian-vs-Asian |
3.840000E-01 |
| AfricanAmerican-vs-Asian |
4.208800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.013200E-04 |
| Normal-vs-Female |
3.713600E-01 |
| Male-vs-Female |
1.099720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.344450E-01 |
| Normal-vs-Extreme_Weight |
1.350190E-02 |
| Normal-vs-Obese |
5.249800E-02 |
| Normal-vs-Extreme_Obese |
2.927000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.846000E-01 |
| Normal_Weight-vs-Obese |
8.452600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.590600E-01 |
| Extreme_Weight-vs-Obese |
4.554200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.814810E-01 |
| Obese-vs-Extreme_Obese |
4.910200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.291000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.195500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.587700E-04 |
| Normal-vs-Age(81-100Yrs) |
8.078800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.036800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.120410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.287000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.900500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.057000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.165730E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.40559999972645E-07 |
| Normal-VS-Type2 PRCC |
4.430000E-02 |
| Normal-VS-KIRP CIMP |
8.743100E-03 |
| Normal-VS-Unclassified PRCC |
4.077200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.99440505513849E-15 |
| Type1 PRCC-VS-KIRP CIMP |
8.01450017462457E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
4.821200E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.910600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.022400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.444000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.036400E-01 |
| Normal-vs-N1 |
7.415600E-01 |
| Normal-vs-N2 |
1.216450E-01 |
| N0-vs-N1 |
3.100200E-01 |
| N0-vs-N2 |
2.302200E-01 |
| N1-vs-N2 |
3.722800E-01 |
|
|
